Greenyn Biotechnology Co., Ltd.(TW:6846)
NT$49.000.00 (0.00%)
TW:6846
Greenyn Biotechnology Co., Ltd. financials statements
NT$49.00
At close:0.00 (0.00%)
Greenyn Biotechnology Co., Ltd. (6846) Income Statement
Greenyn Biotechnology Co., Ltd. Income Statement
Last quarter (Q2 2026), Greenyn Biotechnology Co., Ltd.'s total revenue was NT$195.76M, a decrease of 6.24% from the same quarter last year. In Q2, Greenyn Biotechnology Co., Ltd.'s net income was NT$14.91M. See Greenyn Biotechnology Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Sep 22 |
|---|---|---|---|---|---|
| NT$ 915.32M | NT$ 873.24M | NT$ 800.51M | NT$ 705.31M | NT$ 693.77M | |
| NT$ 440.04M | NT$ 415.23M | NT$ 392.46M | NT$ 370.93M | NT$ 358.02M | |
| NT$ 251.40M | NT$ 247.37M | NT$ 231.61M | NT$ 204.24M | NT$ 188.89M | |
| Depreciation and Amortization | NT$ 35.44M | NT$ 30.61M | NT$ 24.92M | NT$ 25.14M | NT$ 23.28M |
| NT$ 224.08M | NT$ 215.81M | NT$ 192.40M | NT$ 210.40M | NT$ 193.67M | |
| NT$ 188.63M | NT$ 167.86M | NT$ 159.82M | NT$ 185.26M | NT$ 170.39M | |
| NT$ -3.67M | NT$ 15.84M | NT$ 6.01M | NT$ -1.25M | NT$ -105.00K | |
| NT$ 184.96M | NT$ 183.70M | NT$ 165.83M | NT$ 184.01M | NT$ 169.02M | |
| NT$ 145.52M | NT$ 146.00M | NT$ 130.66M | NT$ 146.74M | NT$ 132.78M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 5.39 | NT$ 5.45 | NT$ 5.04 | NT$ 6.01 | NT$ 5.46 |
| Diluted EPS | NT$ 5.39 | NT$ 5.40 | NT$ 4.99 | NT$ 5.93 | NT$ 5.21 |
| Weighted Average Shares Outstanding | 27.00M | 26.88M | 25.93M | 24.41M | 24.31M |
| Weighted Average Shares Outstanding (Diluted) | 27.00M | 27.09M | 26.18M | 24.75M | 25.49M |
Currency in TWD
